T 0217/13 of 15.01.2018
- European Case Law Identifier
- ECLI:EP:BA:2018:T021713.20180115
- Date of decision
- 15 January 2018
- Case number
- T 0217/13
- Petition for review of
- -
- Application number
- 04762945.6
- IPC class
- A61M 5/142
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- MEDICAL INJECTION DEVICE MOUNTABLE TO THE SKIN
- Applicant name
- Novo Nordisk A/S
- Opponent name
- Roche Diabetes Care AG
Sanofi-Aventis Deutschland GmbH - Board
- 3.2.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54(3)Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 13(1)
- Keywords
- Admissibility of requests - 1st to 5th and 11th to 14th auxililary requests (yes); 15th auxiliary request (no)
Novelty - 1st to 4th, 6th and 11th to 14th auxiliary requests (no)
Added subject-matter - 5th auxiliary request (yes) - unallowable disclaimer - Catchword
- -
- Cited cases
- G 0001/03
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.